Cargando…
JAK‐STAT core cancer pathway: An integrative cancer interactome analysis
Through a comprehensive review and in silico analysis of reported data on STAT‐linked diseases, we analysed the communication pathways and interactome of the seven STATs in major cancer categories and proposed rational targeting approaches for therapeutic intervention to disrupt critical pathways an...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980946/ https://www.ncbi.nlm.nih.gov/pubmed/35229974 http://dx.doi.org/10.1111/jcmm.17228 |
_version_ | 1784681502517231616 |
---|---|
author | Erdogan, Fettah Radu, Tudor Bogdan Orlova, Anna Qadree, Abdul Khawazak de Araujo, Elvin Dominic Israelian, Johan Valent, Peter Mustjoki, Satu M. Herling, Marco Moriggl, Richard Gunning, Patrick Thomas |
author_facet | Erdogan, Fettah Radu, Tudor Bogdan Orlova, Anna Qadree, Abdul Khawazak de Araujo, Elvin Dominic Israelian, Johan Valent, Peter Mustjoki, Satu M. Herling, Marco Moriggl, Richard Gunning, Patrick Thomas |
author_sort | Erdogan, Fettah |
collection | PubMed |
description | Through a comprehensive review and in silico analysis of reported data on STAT‐linked diseases, we analysed the communication pathways and interactome of the seven STATs in major cancer categories and proposed rational targeting approaches for therapeutic intervention to disrupt critical pathways and addictions to hyperactive JAK/STAT in neoplastic states. Although all STATs follow a similar molecular activation pathway, STAT1, STAT2, STAT4 and STAT6 exert specific biological profiles associated with a more restricted pattern of activation by cytokines. STAT3 and STAT5A as well as STAT5B have pleiotropic roles in the body and can act as critical oncogenes that promote many processes involved in cancer development. STAT1, STAT3 and STAT5 also possess tumour suppressive action in certain mutational and cancer type context. Here, we demonstrated member‐specific STAT activity in major cancer types. Through systems biology approaches, we found surprising roles for EGFR family members, sex steroid hormone receptor ESR1 interplay with oncogenic STAT function and proposed new drug targeting approaches of oncogenic STAT pathway addiction. |
format | Online Article Text |
id | pubmed-8980946 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89809462022-04-11 JAK‐STAT core cancer pathway: An integrative cancer interactome analysis Erdogan, Fettah Radu, Tudor Bogdan Orlova, Anna Qadree, Abdul Khawazak de Araujo, Elvin Dominic Israelian, Johan Valent, Peter Mustjoki, Satu M. Herling, Marco Moriggl, Richard Gunning, Patrick Thomas J Cell Mol Med Original Articles Through a comprehensive review and in silico analysis of reported data on STAT‐linked diseases, we analysed the communication pathways and interactome of the seven STATs in major cancer categories and proposed rational targeting approaches for therapeutic intervention to disrupt critical pathways and addictions to hyperactive JAK/STAT in neoplastic states. Although all STATs follow a similar molecular activation pathway, STAT1, STAT2, STAT4 and STAT6 exert specific biological profiles associated with a more restricted pattern of activation by cytokines. STAT3 and STAT5A as well as STAT5B have pleiotropic roles in the body and can act as critical oncogenes that promote many processes involved in cancer development. STAT1, STAT3 and STAT5 also possess tumour suppressive action in certain mutational and cancer type context. Here, we demonstrated member‐specific STAT activity in major cancer types. Through systems biology approaches, we found surprising roles for EGFR family members, sex steroid hormone receptor ESR1 interplay with oncogenic STAT function and proposed new drug targeting approaches of oncogenic STAT pathway addiction. John Wiley and Sons Inc. 2022-03-01 2022-04 /pmc/articles/PMC8980946/ /pubmed/35229974 http://dx.doi.org/10.1111/jcmm.17228 Text en © 2022 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Erdogan, Fettah Radu, Tudor Bogdan Orlova, Anna Qadree, Abdul Khawazak de Araujo, Elvin Dominic Israelian, Johan Valent, Peter Mustjoki, Satu M. Herling, Marco Moriggl, Richard Gunning, Patrick Thomas JAK‐STAT core cancer pathway: An integrative cancer interactome analysis |
title | JAK‐STAT core cancer pathway: An integrative cancer interactome analysis |
title_full | JAK‐STAT core cancer pathway: An integrative cancer interactome analysis |
title_fullStr | JAK‐STAT core cancer pathway: An integrative cancer interactome analysis |
title_full_unstemmed | JAK‐STAT core cancer pathway: An integrative cancer interactome analysis |
title_short | JAK‐STAT core cancer pathway: An integrative cancer interactome analysis |
title_sort | jak‐stat core cancer pathway: an integrative cancer interactome analysis |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980946/ https://www.ncbi.nlm.nih.gov/pubmed/35229974 http://dx.doi.org/10.1111/jcmm.17228 |
work_keys_str_mv | AT erdoganfettah jakstatcorecancerpathwayanintegrativecancerinteractomeanalysis AT radutudorbogdan jakstatcorecancerpathwayanintegrativecancerinteractomeanalysis AT orlovaanna jakstatcorecancerpathwayanintegrativecancerinteractomeanalysis AT qadreeabdulkhawazak jakstatcorecancerpathwayanintegrativecancerinteractomeanalysis AT dearaujoelvindominic jakstatcorecancerpathwayanintegrativecancerinteractomeanalysis AT israelianjohan jakstatcorecancerpathwayanintegrativecancerinteractomeanalysis AT valentpeter jakstatcorecancerpathwayanintegrativecancerinteractomeanalysis AT mustjokisatum jakstatcorecancerpathwayanintegrativecancerinteractomeanalysis AT herlingmarco jakstatcorecancerpathwayanintegrativecancerinteractomeanalysis AT morigglrichard jakstatcorecancerpathwayanintegrativecancerinteractomeanalysis AT gunningpatrickthomas jakstatcorecancerpathwayanintegrativecancerinteractomeanalysis |